TO Rastreando

The TO Rastreando Application is composed of textual materials that explain the selected protocols, from the cognitive domains they assess, their application, scoring and interpretation, to the guidelines and referrals to be taken based on the result found. In each tab referring to the tests, you can see the explanation about the use and interpretation of the referred instrument, the protocol itself and its validation article in Brazil.
Based on this detail, the structure of the educational technology was defined as follows: the main screen has seven icons, six of which expose the following cognitive screening protocols each: 10 – Point Cognitive Screneer (10- CS); Consurtiom to Stabilize a Registry for Alzheimer’s Disease (CERAD), better known as the Word List Test; Mini Mental State Examination (MMSE); Clock Test (TR); Verbal Fluency Test (VF) and Geriatric Depression Scale (GDS-15). The seventh icon presents the topic Guidance and Referrals, which discusses possible diseases that may occur with cognitive decline and how to proceed after applying the tests.
The “Information” icon presents the Theoretical Foundation and in the “About” icon you can find the application's Objectives, the Target Audience, as well as those responsible for its creation. On the last screen is the Privacy Policy.
It is important to point out that the icon referring to the Clock Test does not provide the protocol itself because, according to the validation article used, the circle design referring to the clock already constitutes an element to be evaluated.
In addition, it is also worth mentioning that, as it is an Educational Technology (ET), it is believed that it is important for the user to know the reference of each content exposed on the platform.
Cognitive screening is the assessment of a person's cognitive functions. It can be performed through the application of scientifically validated instruments, in order to identify the existence or not of deficits in this area. In the elderly population, this screening becomes essential to detect the existence of Cognitive Decline, Mild Cognitive Impairment (MCI), Dementia or even Depression and other neurological and/or psychiatric diseases. It also allows its evaluators to develop a clinical reasoning about the possible causes of cognitive impairment.
The diagnosis/early detection of cognitive impairments and the measurement of their severity are important to assist in the elaboration of an individualized treatment plan that is more adequate to the real needs of the elderly person through therapeutic interventions more directed to the presented deficit. Thus, it is expected to obtain a higher rate of benefits and avoid or postpone the onset of a possible dementia, preserve the autonomy and independence of the elderly person, prevent family illness and reduce the risk of accidents (CODOSH, 2004; GUPTA et al. ., 2019; EXNER; BATISTA; ALMEIDA, 2018).